Orchard Therapeutics Plc
ORTX
Revenue
6.30M
▼-1.01M▼-13.84%
3 Months ChangeAssets
202.27M
▼-30.04M▼-12.93%
3 Months ChangeLiabilities
122.01M
▼-1.25M▼-1.01%
3 Months ChangeFree Cash Flow
-30.02M
▼-10.03M▼-50.13%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-01-24
Form 8-K
ID: 0001193125-24-014239
2024-01-22
Form 8-K
ID: 0001193125-24-012165
2023-12-19
Form 8-K
ID: 0001193125-23-298673
2023-12-08
Form 8-K
ID: 0001193125-23-291732
2023-11-30
Form 8-K
ID: 0001193125-23-286265
2023-11-21
Form 8-K
ID: 0001193125-23-281087
2023-11-13
Form 10-Q
ID: 0000950170-23-062428
2023-11-13
Form 8-K
ID: 0000950170-23-062423
2023-10-26
Form 8-K
ID: 0000950170-23-055650
2023-10-05
Form 8-K
ID: 0001193125-23-251143